论文部分内容阅读
Background Our purpose was to perform a meta-analysis of controlled trials evaluating safety and efficacy of everolimus-eluting stents (EES) compared with paclitaxel-eluting stents (PES) in patients with diabetes mellitus undergoing percutaneous coronary intervention (PCI).